Overweight and obesity are markers of a single unifying metabolic dysfunction - insulin resistance. Rather than continuing to put individuals in discrete risk stratification categories based on ideal body weight, it is more useful to consider it as a continuum of dysfunction. This talk will explore the evidence behind the recommendations for various diets, nutraceuticals, and other approaches to weight loss and management.